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The mechanisms by which transcription factor hap-
loinsufficiency alters the epigenetic and transcrip-
tional landscape in human cells to cause disease are
unknown. Here, we utilized human induced pluripo-
tent stem cell (iPSC)-derived endothelial cells (ECs)
to show that heterozygous nonsense mutations in
NOTCH1 that cause aortic valve calcification disrupt
the epigenetic architecture, resulting in derepression
of latent pro-osteogenic and -inflammatory gene net-
works. Hemodynamic shear stress, which protects
valves from calcification in vivo, activated anti-osteo-
genic and anti-inflammatory networks in NOTCH1+/+,
but notNOTCH1+/, iPSC-derivedECs.NOTCH1hap-
loinsufficiency altered H3K27ac at NOTCH1-bound
enhancers, dysregulating downstream transcription
of more than 1,000 genes involved in osteogenesis,
inflammation, and oxidative stress. Computational
predictions of the disrupted NOTCH1-dependent
gene network revealed regulatory nodes that, when
modulated, restored the network toward the
NOTCH1+/+ state. Our results highlight how alter-
ations in transcription factor dosage affect gene net-
works leading to human disease and reveal nodes
for potential therapeutic intervention.INTRODUCTION
Human disease is often caused by genetic variants that quanti-
tatively affect dosage of the encoded gene product, particularly
those involving major regulatory factors. The use of induced
pluripotent stem cells (iPSCs) has facilitated the understanding
of many human diseases, but it remains unclear how reduction1072 Cell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc.in dosage of transcriptional regulators selectively affects the
transcription of target genes, alters the epigenetic landscape,
and perturbs gene networks resulting in disease. The ability to
model haploinsufficiency of a transcription factor (TF) in human
iPSCs combined with integration of broad ‘‘-omic’’ data may
reveal mechanisms underlying dose sensitivity of regulatory
proteins and novel targets for intervention.
We previously reported two families with heterozygous
nonsense mutations in the membrane-bound TF, NOTCH1
(N1), which led to a congenital defect of the aortic valve known
as bicuspid aortic valve (BAV) and severe aortic valve calcifica-
tion in adults (Garg et al., 2005). Calcific aortic valve disease
(CAVD) is the third leading cause of adult heart disease and is
responsible for more than 100,000 valve transplants annually in
the United States alone (Garg et al., 2005). BAV, which occurs
in 1%–2% of the population and involves the formation of two
valve leaflets rather than the normal three leaflets, is a major
risk factor for early valve calcification, although the mechanism
for the calcification is unknown (Go et al., 2014). Recent studies
identified N1 mutations in additional familial cases of BAV and
CAVD, as well as 4% of sporadic cases, underscoring the
importance of N1 in this disease (Foffa et al., 2013; Mohamed
et al., 2006).
Hemodynamic shear stress protects against aortic valve calci-
fication in adults, similar to shear-induced protection against
atherosclerosis and vascular calcification. Accordingly, the first
region of the valve to calcify is the aortic side, which experiences
less laminar shear stress than the ventricular side (Weinberg
et al., 2010). Shear stress activates signaling through the N1
transmembrane receptor in endothelial cells (ECs) in vitro, and
NOTCH signaling in vivo is greater on the ventricular side of the
aortic valve (Combs and Yutzey, 2009; Masumura et al., 2009).
Furthermore, in mice, EC-specific deletion of the Notch ligand
Jagged1 leads to valve malformations and aortic valve calcifica-
tion (Hofmann et al., 2012). These findings suggest that N1
signaling in the endothelium is uniquely positioned to mediate
the anti-calcific response to shear stress within the valve.
Here, we utilized human iPSC-derived ECs to show that het-
erozygous nonsense mutations in N1 disrupt the epigenetic
architecture, resulting in derepression of latent pro-osteogenic
and -inflammatory gene networks. Hemodynamic shear stress
activated anti-osteogenic and anti-inflammatory networks in
N1+/+, but not N1+/–, iPSC-derived ECs. N1 haploinsufficiency
altered H3K27ac at N1-bound enhancers, dysregulating
downstream transcription of more than 1,000 genes involved in
osteogenesis, inflammation, and oxidative stress. Computa-
tional predictions of the disrupted N1-dependent gene network
revealed regulatory nodes that, when modulated, restored the
network toward the wild-type (WT) state. Our results highlight
how alterations in TF dosage affect gene networks leading to
human disease and reveal nodes for potential therapeutic
intervention.
RESULTS
Transcriptional States in EC Differentiation
and Response to Shear Stress
To investigate the consequences of N1 heterozygosity in ECs,
we first needed to describe the normal transcriptional and epige-
netic state of human ECs during differentiation and under static
and fluid shear stress conditions. We therefore differentiated
two human embryonic stem cell (ESC) lines (H7 and H9) and
three human iPSC lines into ECs using a protocol previously
developed in our lab (Figure 1A) (White et al., 2013). We collected
cells at key stages of EC differentiation: undifferentiated pluripo-
tent cells, mesodermal precursors (MesoPs), EC precursors
(ECPs), and ECs that we exposed to either static or laminar
shear stress conditions to model the effects of hemodynamic
shear stress on the ventricular side of the aortic valve (Figure 1A).
We only conducted experiments on ECPs and ECs that were
70%–100% pure for their respective markers by fluorescence-
activated cell sorting (FACS) (Figures S1A and S1B).
We first identified the unique signature of key stages of EC
differentiation using RNA sequencing (RNA-seq) data from
each aforementioned cell population (Figure 1B and Tables S1
and S2). As expected, genes related to cell division and stem
cell maintenance defined pluripotent cells, whereas genes
involved in WNT, HEDGEHOG, and BMP signaling were
enriched in MesoPs. By the ECP stage, genes involved in angio-
genesis and MAPK signaling were upregulated, indicating the
commencement of EC specification. NOTCH signaling was a
unique feature of the final shear-responsive EC stage. ECs also
showed upregulation of matrix metalloproteinases (MMPs),
which are involved in degrading extracellular matrix (ECM)
(Vu and Werb, 2000).
Genes upregulated in shear stress conditions were involved
in antagonizing pro-osteogenic BMP and TGFb signaling
pathways and included TFs such as SMAD6 and SMAD7 and
secreted factors such as GREM1 (Figure 1B) (Bragdon et al.,
2011). The secreted factors may provide a mechanism for ECs
exposed to shear stress to prevent the calcification of underlying
valve interstitial cells (VICs). Additionally, shear-stress-upregu-
lated genes involved factors that increase the resistance to
oxidative damage, including NQO1 and TXNRD1 (Gorrini et al.,
2013). Using a random forest machine learning approach toidentify stage-predictive TFs from the RNA-seq data, we found
that static conditions were predicted by expression of genes
encoding inflammatory proteins, including STAT6, NFKB2, and
IRF9, all of which were downregulated by shear stress, while
the TF most predictive of shear stress conditions was SMAD6,
which inhibits BMP signaling (Figures 1C and S1C) (Hervas-
Stubbs et al., 2011).
To investigate whether the anti-inflammatory and anti-osteo-
genic effects of shear stress were mediated by changes in
genome occupancy of these key TFs, we tested the distribution
of their putative occupancy sites based on motif analysis
within active enhancers or repressed regions as identified by
H3K27ac and H3K27me3 chromatin immunoprecipitation
sequencing (ChIP-seq), respectively, in human iPSC-derived
ECs (Figure 1D). In static conditions, we found a unique over-
representation of pro-inflammatory STAT and IRF motifs in
H3K27ac-marked enhancers. By contrast, H3K27ac enhancers
in the shear stress condition showed a unique overrepresenta-
tion of anti-inflammatory and anti-oxidant NRF2 motifs and
TGFb-inhibitory JUN motifs (Dennler et al., 2000; Gorrini et al.,
2013). H3K27me3-marked repressive regions in shear stress
conditions showed a unique overrepresentation of SMAD2/3/4
motifs, suggesting repression of pro-osteogenic TGFb signaling
in shear stress conditions. Thus, shear stress may protect
against calcification by antagonizing pro-osteogenic BMP and
TGFb signaling pathways and repressing pro-inflammatory
STAT and IRF signaling pathways at the transcriptional and
epigenetic level (Figure 1E).
Dynamic Chromatin States Correlated with Distinct
Transcriptional Patterns
To understand the epigenetic changes occurring near the tran-
scriptional start sites (TSSs) of dynamically expressed genes,
we performed ChIP-seq for the H3K4me3 active promoter
mark, H3K27ac active enhancer mark, H3K4me1 poised/active
mark, and H3K27me3 repressive mark across EC differentiation
(Rada-Iglesias et al., 2011; Wamstad et al., 2012) (Figures 2A
and 2B and Table S3). Dynamic changes in histone modifica-
tions at promoters fell into distinct clusters. To test whether dy-
namic histone modifications correlated with distinct transcrip-
tional patterns to distinguish functional groups of co-
expressed genes, we compiled genes shared between each
chromatin and expression cluster and determined statistical
enrichment (Figure 2C). Most expression clusters correlated
with multiple chromatin clusters. For example, expression clus-
ter F contained genes highly transcribed at the MesoP stage,
which were enriched in chromatin clusters 3–8 and 14–15. Pre-
vious studies have shown that genes important for early devel-
opment often correlate with a chromatin modification pattern
similar to that of chromatin cluster 8, which includes a high level
of repressive H3K27me3 at the pluripotent stage that is then
relieved to allow expression during early development (Rada-
Iglesias et al., 2011). Indeed, we found that there was a sig-
nificant enrichment in cluster F of genes annotated as develop-
mental within chromatin cluster 8 compared to genes annotated
as non-developmental (Figure S1D). This indicated that chro-
matin cluster 8 identified a specific functional subset of genes
in expression cluster F.Cell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc. 1073
Figure 1. Transcriptional Mechanisms in EC Differentiation and Response to Shear Stress
(A) Stages of EC differentiation analyzed.
(B) Unique signature of EC differentiation stages by RNA-seq. Stage-unique genes were expressed most highly at the given stage and significantly upregulated
relative to immediately preceding or following stages. p < 0.05 by negative binomial test with false discovery rate (FDR) correction.
(C) Top stage-predictive TFs identified by random forest classifier.
(D) Left: expression of TFs whose motifs were tested in the corresponding rows on the right. Right: motif enrichment within activating or repressive chromatin
marks in ECs exposed to static or shear stress conditions suggesting activated or repressed signaling pathways. Any color indicates significant motif enrichment
(q < 0.05) by motifDiverge with FDR correction, whereas white indicates non-significance. Red up flags: activating marks; blue down flags: repressive marks.
(E) Left: diagram of static-specific pro-inflammatory genes (pink). Right: diagram of shear-specific anti-osteogenic genes (violet).
In (B–D): n = 5. See also Figure S1 and Tables S1 and S2.
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Figure 2. Correlation of Dynamic Chromatin Patterns with Transcriptional Transitions
(A) Hierarchical clustering of mRNA expression.
(B) Hierarchical clustering of genes based on enrichment of histone modifications within 1 kb of the TSS. Color indicates mean enrichment for each gene cluster.
Red up flags: activating marks; blue down flags: repressive marks.
(C) The overlap of genes within expression clusters (horizontal axis) and chromatin clusters (vertical axis). Color represents X2 residuals (any yellow indicates
significant overlap between genes in the corresponding expression and chromatin cluster).
(D) Histone modification enrichment around TAL1 (Cluster J) during EC differentiation.
In (A–D): n = 5. See also Figure S1 and Tables S3 and S4.Conversely, some expression clusters correlated strongly with
a single chromatin cluster. For example, expression cluster J
predominantly clustered with chromatin cluster 10. While genes
expressed in J showed very specific upregulation at the
ECP stage, chromatin cluster 10 was characterized by stable
H3K4me3 and H3K27ac activating marks throughout differen-
tiation. All other expression clusters correlating with this non-dynamic chromatin cluster included genes upregulated at the
ECP stage. This pattern was upheld even when evaluating chro-
matin marks up to 15 kilobases (kb) from gene TSSs.
The aforementioned random forest approach to discern
stage-predictive TFs identified several ECP-predictive TFs that
may confer the specificity of cluster J genes, including SCL1/
TAL1, an important regulator of ECPs and vasculogenesis, inCell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc. 1075
addition to hematopoiesis (Drake et al., 1997; Liao et al., 1998;
Van Handel et al., 2012) (Figure 1C). Unlike other cluster J genes
that showed consistently active promoters throughout differenti-
ation, H3K4me3 and H3K27ac marked the TAL1 promoter most
strongly at the ECP stage (Figure 2D), when TAL1 drives critical
fate decisions (Van Handel et al., 2012). Additionally, repressive
H3K27me3 marked the TAL1 promoter at prior stages, suggest-
ing that its repression may prevent premature activation of
downstream ECP gene networks. TAL1 gene expression was
elevated in ECPs, but TAL1 DNA-binding motifs were not en-
riched in any stage-specific enhancers throughout EC differen-
tiation. Thus, genes expressed at the pivotal ECP specification
stage maintain an epigenetic state primed for transcriptional
activation throughout differentiation and may rely on the expres-
sion of a discrete set of regulators such as TAL1 to confer
temporal specificity. Only 11 other cluster J genes shared
TAL1’s dynamic chromatin pattern (chromatin cluster 24). These
included GATA2, a known cofactor of EC regulator ETV2
(Shi et al., 2014), as well as genes with no previously known
role in EC differentiation, such as C16orf74, that may represent
novel ECP regulators. Together, these ECP-enriched genes
and their targets activate genes critical for downstream endo-
thelial development such as ANGPT2, a known TAL1 target
gene that is required for postnatal angiogenesis (Deleuze et al.,
2012), maintaining a high level of activation in ECs under both
static and shear stress conditions (Figure S1E).
We next investigated whether chromatin clusters could
discern functional groups of genes involved in the response to
shear stress. Two groups of expression clusters contained static
or shear-stress-specific gene expression: K–L and P–Q. While
K–L was enriched for cytoskeletal genes, P–Q was enriched for
genes involved in SMAD signaling and blood vessel develop-
ment. We focused on expression clusters P and Q to test
whether the associated chromatin clusters could distinguish
functional gene groups important for the anti-calcific effects of
shear stress (Table S4). Gene ontology (GO) term enrichment
in individual expression-chromatin cluster intersections showed
that static-specific cluster intersections P22 and P25 contained
immune process and interleukin signaling factors, respectively.
However, when intersected with shear-specific genes, the
same chromatin clusters, 22 and 25, were associated with
TGFb signaling antagonism (including ENG and INHBA) and
bone mineralization (including inhibitory GREM1) (Bragdon
et al., 2011; Guo et al., 2004). Additional shear-specific cluster
intersection Q24 contained activin-binding genes such as
FSTL3, an inhibitor of TGFb signaling (Bragdon et al., 2011).
Thus, chromatin clusters were able to distinguish immune pro-
cess-related genes active in the static condition and antagonism
of pro-osteogenic TGFb signaling in shear stress conditions.
Isogenic iPSC-Derived ECsModel N1Haploinsufficiency
We sought to understand how N1 heterozygosity perturbs the
normal EC gene expression and epigenetic state to cause
CAVD. We derived and characterized iPSCs from the fibroblasts
of three individuals from two families affected with CAVD due to
heterozygous nonsense mutations in N1 (Figures 3A, S2A–S2E,
and S3). Additionally, we derived and characterized iPSCs from
a related individual who was N1+/+ and unaffected by CAVD.1076 Cell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc.As unrelated controls, we used two established ESC lines (H7
and H9) and two previously established iPSC lines.
To derive isogenic control lines, we corrected the N1mutation
using TALENs (Figures 3A and S4A–S4D). We detected no off-
target effects by Southern blot for the donor DNA and compared
multiple corrected N1+/+ clones to multiple TALEN-targeted
but uncorrected N1+/– clones to control for any effects of the
TALEN-targeting process. We differentiated control and mutant
iPSCs into ECs and exposed them to either static or shear stress
conditions to model the anti-calcific effects of shear stress.
Using isogenic cell lines, we found that N1 mRNA levels
were reduced by 30%–40% in the N1+/– ECs by RNA-seq (Fig-
ure 3B). Additionally, 70%–100% of N1 mRNA present in N1+/–
ECs was transcribed from the WT allele, suggesting that the
mutant mRNA largely undergoes nonsense-mediated decay
(FigureS5D). This indicated that the iPSC-derivedECswereeffec-
tively modeling a decreased dosage of N1. N1+/– ECs showed
increased levels ofNOTCH4mRNA,which encodes the otherma-
jor NOTCH protein in ECs and reflects a possible compensatory
response. Although N1+/– ECs did not exhibit altered
differentiation capacity, their transcriptome clustered separately
from isogenicN1+/+ECs (Figures S4C andS5A). Furthermore, ca-
nonical N1 targets, including HES1 and EFNB2, were down-
regulated inN1+/– ECs, indicating thatN1+/– ECswere haploinsuf-
ficient for N1 activity, at least at some targets (Figure 3C).
Gene Networks Dysregulated due to N1
Haploinsufficiency
RNA-seq of iPSC-derived ECs in static conditions revealed that
929 mRNAs were dysregulated in N1+/– ECs, whereas in shear
stress conditions, 791 mRNAs were altered (with approximately
half being dysregulated in both conditions) (Figures 3D and 3G
and Table S5). GO analysis showed that NOTCH and DELTA-
NOTCH signaling were among the top pathways dysregulated
in N1 haploinsufficiency (shear and/or static conditions), indi-
cating that the N1+/– iPSC-derived ECs were indeed modeling
a defect in N1 activity (Figure 3E and Table S6). Furthermore,
top dysregulated GO pathways included endochondral ossifica-
tion and inflammatory response, two pathways thought to play
a major role in CAVD. In addition, 180 small non-coding RNAs
(ncRNAs) were significantly dysregulated inN1+/– ECs, and these
were enriched for miRNAs and CDBox RNAs (Figures S5B and
S5C). Surprisingly, no ncRNAs were significantly dysregulated
under shear stress, indicating that shear-stress-induced N1
signaling may be sufficient to restore ncRNA networks in N1+/–
ECs to their WT state, similar to the shear-stress-induced resto-
ration of a subset of dysregulated mRNAs. ncRNAs altered in
N1+/– ECs reflected similar processes as observed for dysregu-
lated mRNAs. Anti-osteogenic (e.g., miR-20a, 26a, 30e, and
106a) and anti-atherogenic miRNAs (e.g., miR-126) were down-
regulated in N1+/– ECs, whereas pro-osteogenic (e.g., miR-30d)
and pro-atherogenic (e.g., miR-663) miRNAs were upregulated
(Goettsch et al., 2013; Li et al., 2013; Schober et al., 2014).
When we tested whether unique features of the shear stress
condition were dysregulated in N1 heterozygosity, we found
that N1+/– ECs did not properly activate anti-calcific genes
normally induced by shear stress (Figures 3D and 3F). In total,
30% of shear-responsive genes in WT ECs were dysregulated
Figure 3. Gene Networks Dysregulated in N1 Haploinsufficient Isogenic iPSC-Derived ECs
(A) Pedigrees of two families affected with congenital heart disease and valve calcification due to N1 mutations. Squares, males; circles, females.
(B) mRNA expression of N1 and compensatory upregulation of NOTCH4.
(C) mRNA expression of canonical N1 targets HES1 and EFNB2.
(D) Log2 fold change in mRNA expression in N1
+/– versus WT ECs in static and shear stress conditions of 1,303 genes significantly dysregulated in N1+/– ECs.
(E) Top GO pathways enriched among genes dysregulated in N1+/– ECs.
(F) Examples of anti-osteogenic (GREM1 and DKK1), antioxidant (TXNRD1), and anti-atherogenic (CYP1B1) shear-responsive genes not properly activated in
N1+/– ECs.
(G) Overlap of statistically significant gene sets.
In (B–G): WT n = 3,N1+/– n = 2 (isogenic ECs); error bars represent SE; *p < 0.05 by negative binomial test with FDR correction. See also Figures S2, S3, S4, and S5
and Tables S5 and S6.
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inN1+/– ECs and were thus N1 dependent (Figure 3G).N1+/– ECs
showed downregulation of shear-specific antagonists of pro-
osteogenic BMP andWNT pathways, including genes producing
secreted proteins GREM1 and DKK, respectively (Van Handel
et al., 2012). Furthermore, shear-exposedN1+/– ECs failed to up-
regulate anti-atherogenic factors such as CYP1B1 and showed
aberrant upregulation of pro-inflammatory genes, including
IRF6 (Conway et al., 2009; Kwa et al., 2014). In both static and
shear stress conditions, N1+/– ECs showed an increase in cell-
cycle genes such as CDC20 and CDCA2 (with additional genes
such as CCNA1 and CCND1 activated in static conditions).
Furthermore, we observed downregulation of PDE3A and upre-
gulation of PDE2A, which would be predicted to alter EC perme-
ability and promote inflammatory cell infiltration (Surapisitchat
et al., 2007). Finally, when exposed to shear stress, N1+/– ECs
did not appropriately upregulate genes involved in the oxidative
stress response such as CYGB and TXNRD1 (Li et al., 2007) and
showed downregulation of MMPs such as MMP7 and 9 (with
additional MMPs 10, 19, and 24 downregulated in static condi-
tions) (Figure S5E). Overall, N1 haploinsufficient ECs could not
mediate the normal anti-calcific response induced by shear
stress and showed aberrant upregulation of pro-osteogenic
and inflammatory signaling.
Epigenetic Dysregulation Correlated with Pro-calcific
Gene Expression in N1+/– ECs
To determine whether decreased dosage of N1 perturbed the
epigenetic state of genes dysregulated in N1+/– ECs, we per-
formed genome-wide ChIP-seq for H3K4me3, H3K27ac,
H3K4me1, and H3K27me3 in WT or N1+/– patient-specific
iPSC-derived ECs under static and shear stress conditions.
We determined the density of the proximal promoter mark
H3K4me3 within 3 kb of TSSs of genes dysregulated in N1+/–
ECs. Given that H3K27ac, H3K4me1, and H3K27me3 mark
both proximal and distal regulatory domains, we determined
the density of these marks within 15 kb of TSSs of dysregulated
genes.
When we clustered dysregulated genes based on their
expression and epigenetic state in N1+/– ECs compared to WT
ECs, the resulting clusters defined functional groups of genes
involved in distinct aspects of CAVD (Figure 4A). For example,
cluster I contained genes involved in ECM and pro-osteogenic
WNT signaling, which showed increased transcription in both
static and shear stress conditions without much change in any
of the four evaluated chromatin marks. However, cluster J distin-
guished genes involved in pro-osteogenic BMP signaling whose
transcriptional upregulation was accompanied by increased
H3K4me3 and H3K27ac activating marks in both static and
shear stress conditions, as well as decreased H3K27me3
repressive marks in the static condition. Thus, functional groups
of genes shared common epigenetic mechanisms associated
with transcriptional dysregulation in N1+/– ECs.
Focusing on individual genes revealed that histone modifica-
tion changes correlated with pro-calcific gene dysregulation in
N1+/– ECs (Figure 4B). Pro-osteogenic genes involved in endo-
chondral ossification (e.g., PLAU) and osteoblast regulation
(e.g., COL1A1) showed upregulated mRNA expression associ-
ated with increased activating marks H3K4me3, H3K27ac, and1078 Cell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc.H3K4me1 (Engelholm et al., 2001). Conversely, transcriptionally
downregulated anti-calcific factors, including anti-atherogenic
genes such as CYP1B1 and osteoclast genes such as ACP5,
showed decreased H3K27ac activating marks, as well as
increased repressive H3K27me3 marks (Alatalo et al., 2000).
We next investigated whether epigenetic dysregulation in
N1+/– ECs reflected changes in the distribution of key TF motifs
within active and repressed regions (Figure 4C). Epigenetic
studies in WT ECs above showed that pro-inflammatory STAT
and IRF motifs were enriched in H3K27ac-marked enhancers
only in static conditions. Notably, STAT and IRF motifs were
significantly enriched in H3K27ac-marked activation sites in
N1+/– as compared to WT ECs during both static and shear
stress conditions (Figure 4C). This suggests that in N1+/– ECs
there is an even greater increase in STAT and IRF signaling in
static conditions and that these pro-inflammatory signals are
not appropriately downregulated in response to shear stress.
Conversely, H3K27me3-marked repressive domains in WT
ECs were enriched for SMAD2/3/4 motifs in shear stress condi-
tions, whereas H3K27me3 sites in N1+/– ECs were depleted for
SMAD2/3/4 motifs in shear stress, suggesting a de-repression
of pro-osteogenic TGFb signaling as a consequence of N1
haploinsufficiency. Furthermore, in both static and shear stress
conditions, H3K27ac sites in N1+/– ECs were enriched for
RUNX1 motifs compared to WT ECs, likely indicating a pro-
gression to early chondrogenic signaling given RUNX1’s role in
chondroblasts and bone formation (Smith et al., 2005; Yama-
shiro et al., 2004) in addition to its role in hematopoiesis (Okuda
et al., 1996). In sum,N1+/– ECs revealed a shift of activated chro-
matin marks toward putative pro-inflammatory and osteogenic
regulatory domains and a depletion of repressive marks from
putative pro-osteogenic enhancers.
To understand whetherN1+/– ECs underwent more permanent
silencing of regulatory regions that may in principle be related to
disease, we evaluated theDNAmethylation landscape inWT and
N1+/– ECs by whole-genome bisulfite sequencing. We concen-
trated on the static condition as preliminary studies showed
negligible change in methylation status in response to shear
stress assays, which occurred over only 24 hr with little cell
division to allow for methylation turnover. Bisulfite sequencing
revealed 248 differentially methylated regions (DMRs) in N1+/–
ECs compared to WT ECs (Figures 4D and 4E). Nearly half
of these DMRs were novel regions not identified in previous
efforts to capture the dynamic DNA methylation landscape
essential for normal development (Ziller et al., 2013). This
suggests that dysregulation of DNA methylation in disease
settings may partially occur in regulatory domains otherwise
stable throughout development.
DMRs due to N1 haploinsufficiency were significantly enriched
for CpG islands (CpGIs) and shores (± 2 kb from CpGIs) and
depleted for CpG open seas (>4 kb from CpGIs) (Figure 4F).
The largest enrichment of DNA methylation changes occurred
at CpG shore regions, suggesting that these regions might be
the least stable in the disease state. In many regions, changes
in DNA methylation were accompanied with chromatin
mark dysregulation. Regions hypermethylated in N1+/– ECs
lost H3K4me3 or H3K27ac activating marks present in WT
ECs, whereas regions hypomethylated in N1+/– ECs gained
Figure 4. Epigenetic Dysregulation in N1+/– ECs
(A) Hierarchical clustering of genes based on log2 fold change of expression and enrichment of histone modifications within 3 kb (H3K4me3) or 15 kb (H3K27ac,
H3K4me1, and H3K27me3) of the TSS in N1+/– versus WT ECs. Enriched GO pathways within each cluster are shown on the right.
(B)Mean log2 fold change inN1
+/– versusWT static ECs ofmRNA expression and histonemodifications as in (A) of individual pro-osteogenic (PLAU andCOL1A1),
osteoclast (ACP5), and anti-atherogenic (CYP1B1) genes.
(C) TF motif enrichment in N1+/– versus WT chromatin marks in static or shear stress conditions. Motifs tested were drawn from unique clusters identified in
Figure 1D.
(D) Relative mean DNA methylation of CpGs in N1+/– (vertical axis) versus WT (horizontal axis) ECs in static conditions. Plot includes only CpGs with 10–1,0003
total sequence coverage between three biological replicates per experimental group.
(E) Examples of the 248 DMRs identified in N1+/– versus WT ECs.
(F) Distribution of DMRs or all CpGs relative to CpGIs. Shores are <2 kb flanking CpGIs; shelves are <2kb flanking outward from shores; open seas are >4 kb
flanking CpGIs. *p < 0.05 by X2 test with Bonferroni correction.
In (A–C): WT n = 5, N1+/– n = 3 (patient-specific ECs). Red up flags, activating marks; blue down flags, repressive marks. In (D–F): WT n = 3, N1+/– n = 3 (patient-
specific ECs). See also Figure S6 and Table S7.H3K4me3 or H3K27ac marks (Figure S6A). The extensive
conversion of these DMRs between the silenced and activated
state suggests robust changes in the epigenetic landscape of
N1+/– ECs.N1 Binding Sites Showed Dysregulation in H3K27ac
Chromatin Marks in N1+/– ECs
To discern the aspects of transcriptional and epigenetic dysre-
gulation in N1+/– ECs directly associated with N1 genomeCell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc. 1079
occupancy, we performed endogenous N1 ChIP-seq in primary
human aortic ECs (HAECs). We found that 414 of the 1,303
genes dysregulated inN1+/– ECs showed N1 binding in proximity
to their TSSs (within 20 kb) as determined by peaks called in the
N1 ChIP-seq (Figure 5A). Overall, dysregulated genes were
significantly more likely to be found in proximity to a N1 peak
than non-dysregulated genes (p < 0.05). Genes with the most
significant N1 ChIP peaks near their TSSs were most often
downregulated in N1+/– ECs, which is consistent with N1 acting
as a transcriptional activator. However, many putative direct tar-
gets were upregulated in N1 heterozygosity, indicating that N1
might also directly repress pro-calcific genes in WT ECs.
Most N1 binding events occurred in distal intergenic regions,
but binding was most significantly enriched in promoter regions
within 1 kb from TSSs compared to genomic background (Fig-
ure 5B). Putative direct N1 targets whose expression was un-
changed by N1 haploinsufficiency on average showed greater
enrichment of N1 binding near the TSS than targets dysregulated
inN1+/– ECs (Figure 5C). Sites bound with lower levels of N1may
be more sensitive to a reduction in N1 dose, as they may be
closer to a critical occupancy threshold required for gene activa-
tion. To determine motifs enriched in N1 binding sites, we
compared motifs in genomic regions ± 25 base pairs (bps)
fromN1 peak summits tomotifs found in general open chromatin
regions within ECs as determined by H3K27ac ChIP-seq (Fig-
ure 5D). Only 17% of N1 peaks contained the motif bound by
its canonical DNA-binding partner CSL, suggesting that N1
may target DNA through alternate binding partners in ECs. How-
ever, N1-bound sites were enriched for motifs, including RUNX1
motifs, as previously seen in T-lymphoblastic leukemia cells
(Wang et al., 2011), as well as IRF and STAT motifs. Because
RUNX1, IRF, and STAT motifs were all enriched in enhancers
active specifically in N1+/– ECs, N1 complex binding may suffi-
ciently compete with the binding of these TFs in the WT, but
not mutant, state to prevent activation of related pro-osteogenic
and pro-inflammatory signaling pathways.
We next investigated whether histone modifications near
direct N1 binding sites were altered in ECs with decreased
dosage of N1. In WT ECs, genomic regions ± 1 kb from
N1 peak summits were significantly enriched for H3K27ac
and H3K4me1 and depleted, though not significantly, for
H3K27me3 as defined by ChIP-seq (Figure 5E). In contrast,
genomic regions ± 1 kb from N1 peak summits showed sig-
nificant alterations in H3K27ac and to a lesser degree in
H3K4me1 inN1+/– ECs in both static and shear stress conditions
compared to WT ECs (Figures 5F and S6B). N1+/– ECs showed
increased H3K27ac at some sites and decreased H3K27ac
at other sites, suggesting that N1 binding has a locus-specific
effect on H3K27ac. For example, decreased H3K27ac sur-
rounding two N1 binding sites within the gene body of the
previously undescribed target ARHGEF17 correlated with its
significant transcriptional downregulation in static conditions
(Figure 5G).
We clustered N1 binding sites by the change in H3K27ac in
N1 haploinsufficiency compared to WT, which revealed that
the effect of shear stress on H3K27ac at N1 binding sites was
reduced inN1+/– ECs (Figures 5F and 5H). Within N1-bound sites
where shear stress normally increased acetylation (Cluster B),1080 Cell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc.mutant ECs showed less acetylation in shear stress than
WT ECs. Conversely, sites with decreased acetylation in shear
stress (Clusters E–G) showed incomplete deacetylation in
mutant ECs as compared to WT ECs. This dampening of shear
stress effects was less pronounced in distal H3K27ac loci devoid
of N1 binding sites (Figure S6C). However, the pattern was pre-
sent in H3K27ac loci proximal (within 1 kb) to TSSs and distin-
guished functional groups of genes (Figure S6D and Table S7).
For example, promoters of genes encoding inhibitors of pro-
osteogenic WNT signaling (e.g., HBP1 and TLE) (Sampson
et al., 2001; Wu et al., 2014) normally experienced increased
H3K27ac in response to shear stress but showed lower levels
of acetylation in N1+/– ECs as compared to WT ECs in shear
stress conditions. Because almost all N1 binding sites showing
H3K27ac dysregulation were distal from gene TSSs, these
data suggest that N1 binding may mediate the effect of shear
stress on H3K27ac specifically at distal enhancers.
Manipulating Dysregulated Regulatory Nodes
Restores Expression of N1 Downstream Targets
toward WT Levels
We sought to harness our knowledge of the transcriptional and
epigenetic dysregulation caused by N1 haploinsufficiency to
identify putative regulatory nodes within the gene network
downstream of N1 that might serve as therapeutic targets. We
employed a network inference algorithm to predict network
connections using RNA-seq data of WT and N1+/– ECs in static
and shear stress conditions (Margolin et al., 2006). With N1 as
a network hub, we predicted several genes to be directly con-
nected to N1 (Figure 6A). These included the canonical targets
EPHNB2 and HES4, as well as ARHGEF17, which we described
above as a direct N1 target dysregulated in N1+/– ECs. Genes
with putative direct connections to N1 were themselves highly
interconnected, suggesting that these genes might co-regulate
one another to provide additional network stability. Each of these
genes further branched out to connect to particular sets of
genes, such as HES4, which connected to many genes strongly
dysregulated in N1+/– ECs, and ARHGEF17, which connected to
genes that were nearly all highly shear-responsive (Figures S7A
and S7B).
When we expanded our network prediction to include all
dysregulated genes as hubs, we obtained a gene network with
scale-free properties illustrating the predicted connections
between genes downstream of N1 (Figure 6B). Although most
genes were connected to few dysregulated targets, several
genes encoding transcriptional regulators were connected to a
large portion of the genes dysregulated in N1 haploinsufficiency,
suggesting that these putative regulatory nodes may control
the majority of altered genes (Figures 6B and 6C). Among the
nodes connected to the most dysregulated genes were SOX7,
theWNT signaling effector TCF4, and the BMP signaling effector
SMAD1, all upregulated in N1+/– ECs.
Using siRNAs, we corrected the aberrant upregulation of
SOX7, TCF4, or SMAD1, alone or in combination, in an effort
to restore the normal EC gene network.Wemonitored the effects
of these perturbations on the initial putative targets (RASSF4,
THSD1, ACE, PDE2A, and GREM1) selected based on connec-
tions predicted in our inferred gene network (Figure 6D). When
Figure 5. Transcriptional and Epigenetic Dysre-
gulation Directly Associated with N1 Genome
Occupancy
(A) Left: K means clustering of putative direct N1
targets defined as genes significantly dysregulated in
N1+/– ECs with N1 ChIP peaks within 20 kb of the TSS.
Right: significance of N1 peaks within 20 kb of the TSS
of 414 putative direct N1 targets.
(B) Left: distribution of N1 peaks. Right: log2 fold
change of proportion of N1 peaks versus genomic
background in indicated regions. *p < 0.05 by X2 test
with Bonferroni correction.
(C) N1 density around the TSS of genes dysregulated
in N1 haploinsufficiency with N1 peaks within 20 kb
(green), non-dysregulated genes with N1 peaks within
20 kb (orange), or non-dysregulated genes without N1
peaks within 20 kb (blue).
(D) Motifs significantly enriched (q < 0.05 by
motifDiverge with FDR correction) within 25 bps of N1
peak summits compared to H3K27ac peaks in ECs in
static conditions.
(E) Left: Log2 fold change of overlap of chromatin
marks in WT ECs with 1 kb around N1 summits versus
random non-gap genomic loci. *p < 0.05 by X2 test with
Bonferroni correction. Right: H3K27ac density near N1
summits.
(F) Hierarchical clustering based on log2 fold change of
N1+/– versus WT histone modification density within 1
kb of N1 summits. *p < 0.05 by KS test with Bonferroni
correction (histone modification dysregulation around
N1 summits versus random non-gap genomic loci).
(G) Top: N1 peaks and WT or N1+/– H3K27ac near
ARHGEF17. Bottom: mean mRNA expression of
ARHGEF17. Error bars represent SE; *p < 0.05 by
negative binomial test with FDR correction.
(H) Relative H3K27ac density within 1 kb of N1 sum-
mits ordered as in (F) inWT ECs in static or shear stress
conditions.
In (A–H): gene expression: WT n = 3, N1+/– n = 2
(isogenic iPSC-derived ECs). Chromatin marks: WT
n = 5, N1+/– n = 3 (patient-specific iPSC-derived ECs).
N1 genome occupancy: WT n = 1 (union of three
technical replicates) (primary HAECs). Red up flags,
activating marks; blue down flags, repressive marks.
See also Figure S6.
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Figure 6. Manipulation of Dysregulated Regulatory Nodes to Restore the EC Gene Network
(A) Putative regulatory nodes directly connected to N1 in the predicted network and their interconnections (p < 0.05).
(B) Predicted gene regulatory network in ECs (p < 0.05) with each circle representing a gene and color indicating log2 fold change ofN1
+/– versusWT expression in
shear stress conditions. Boxed genes are putative dysregulated regulatory nodes with red and blue boxes indicating up- or downregulated genes, respectively.
(C) Histogram of number of nodes with different numbers of connected dysregulated genes. A small number of master regulators may control the majority of
dysregulated genes.
(D) Effect of control, SOX7, TCF4, and/or SMAD1 siRNA on N1+/– EC mRNA expression of indicated genes as detected by QPCR.
(E) Gene regulatory subcircuit assembled based on perturbation results and network prediction.
(F) Effect of combined SOX7 and TCF4 siRNA on restoring N1+/– versus WT expression of 48 genes dysregulated in N1 haploinsufficiency. N = 2.
See also Figure S7.we intervened solely with SOX7 siRNA, both TCF4 and SMAD1
were restored toward their WT expression levels, indicating
that SOX7 is upstream of these predicted nodes. In addition,1082 Cell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc.the expression of all other putative targets except GREM1
was partially to fully restored to WT levels. Intervening with
TCF4 siRNA also reduced the aberrant upregulation of SOX7,
demonstrating a positive feedback loop between SOX7 and
TCF4. SMAD1 also shifted toward its WT expression, either
through direct regulation by TCF4 or indirect regulation through
SOX7. Knockdown of TCF4 also partially restored the expres-
sion of most putative downstream targets tested (RASSF4,
THSD1, and PDE2A), albeit to a lesser degree than knockdown
of SOX7. However, treating N1+/– ECs with a combination of
SOX7 and TCF4 siRNA had even more dramatic effects in
restoring the WT expression of all putative targets, excluding
GREM1. In contrast, knocking down SMAD1 restored GREM1
expression toward WT levels without affecting SOX7, TCF4,
or any of the other putative targets. Ultimately, based on our
perturbation experiments and network inference, we were
able to identify a gene network sub-circuit involving nodes
SOX7, TCF4, and SMAD1 that controls downstream gene
dysregulation in N1+/– ECs (Figure 6E). N1 is responsible for
repressing this sub-circuit from activation in WT ECs while
decreased N1 levels in N1+/– ECs are insufficient to prevent its
activation.
To determine whether intervening with the SOX7 and TCF4
regulatory nodes had more widespread effects on restoring the
gene network downstream of N1, we expanded our panel to
include 48 genes dysregulated in N1+/– ECs selected based on
our inferred gene network and RNA-seq data (Figure 6F). We
found that the combination of SOX7 and TCF4 siRNA restored
the expression of the majority of these genes toward the WT
state. N1 expression was unaffected, but expression of its ca-
nonical downstream target HES1 was restored toward WT, sug-
gesting possible repair of the pathways downstream of N1
signaling. The siRNA treatment alleviated the downregulation
of genes encoding MMPs (MMP24, MMP9), which may serve
to degrade ECM in the valve, and secreted anti-osteogenic fac-
tors such as theWNT inhibitor DKK1 that may help prevent calci-
fication in underlying VICs. Additionally, the treatment reduced
upregulation of pro-inflammatory genes such as IRF6 and cyto-
kine CXCL12, as well as collagens COL15A1 and COL12A1 that
may contribute to calcification. Overall, correcting the aberrant
upregulation of regulatory nodes SOX7 and TCF4 using siRNA
was able to restore expression of genes within the network dys-
regulated in N1+/– ECs toward the WT state.
DISCUSSION
We have defined the mechanisms critical for normal human EC
differentiation and response to shear stress, determined how
these mechanisms are perturbed in N1 haploinsufficient cells,
and intervened at key regulatory nodes to restore N1+/– ECs to-
ward their WT state. Overall, iPSC-based modeling of human N1
mutations allowed a rigorous interrogation of the gene networks
disrupted in ECs from patients with CAVD to reveal novel targets
for intervention. Moreover, the findings here demonstrate mech-
anisms bywhich dose-reduction of a TF can alter the epigenetics
and transcriptome in a human disease model.
Transcriptional and Epigenetic Mechanisms Governing
EC Differentiation and Response to Shear Stress
Among the more interesting findings from transcriptional and
epigenetic profiling during EC differentiation was that shearstress induced a highly coordinated suppression of pro-osteo-
genic and inflammatory signaling in ECs that may be critical to
protect against calcification events. Shear-dependent histone
modifications correlated with upregulation of anti-osteogenic
genes, including those encoding secreted BMP andWNT antag-
onists that may represent a paracrine signaling method for
shear-exposed ECs to prevent the calcification of neighboring
tissue. Synchronously, shear stress downregulated pro-inflam-
matory cytokines, reduced STAT and IRF signaling effectors
characteristic of ECs in static conditions, and shifted activating
histone modifications toward anti-inflammatory and antioxidant
motifs. It is interesting to consider that ECs throughout the
vasculature may function to repress pro-osteogenic events in
response to laminar shear stress, given the propensity for
calcification at sites of vascular bifurcation experiencing turbu-
lent blood flow.
Transcriptional Consequences of N1 Haploinsufficiency
in iPSC-Based Modeling of CAVD
iPSC-based modeling of human N1 mutations in CAVD re-
vealed that N1 haploinsufficiency disrupts the appropriate
EC response to shear stress (Figures 7A–7C). In contrast
to WT ECs, shear-exposed N1+/– ECs failed to upregulate
anti-osteogenic factors, including secreted BMP and WNT
antagonists that may be critical for preventing calcification of
underlying VICs. They instead overexpressed pro-osteogenic
genes such as BMP4, suggestive of an osteoblast-like switch,
highlighting the importance of the N1-dependent response to
shear stress in maintaining the cell fate of valve ECs. Conver-
sion of valve ECs into osteoblast-like cells has been reported in
disease states (Hofmann et al., 2012), which is consistent with
N1 functioning to repress this aberrant gene program. Interest-
ingly, the secreted anti-osteogenic factor, matrix Gla protein
(MGP), was very lowly expressed in iPSC-derived ECs despite
its abundance in native murine valve tissue (Luo et al., 1997),
making it difficult to determine whether MGP was a shear-
responsive N1 target in human cells. Nevertheless, the tran-
scriptional disturbances in N1+/– ECs indicated a dysregulated
inflammatory environment and vulnerability to oxidative stress
that may fuel the progression of calcification in an aortic valve
without the anti-calcific barriers normally erected by shear-
exposed ECs.
Determining the pathways dysregulated in N1+/– ECs focuses
therapeutic efforts on reinstating the proper EC response
to shear stress and restoring the anti-osteogenic and anti-
inflammatory barriers against calcification in the valve. Further-
more, defining the factors important for maintaining these
barriers provides insight into alternative genes that may be
mutated in CAVD patients without mutations in N1. Future
work delineating whether mutations in various members of
the network preventing CAVD lead to aortic valve disease
may explain why only a portion of patients with BAV progress
to valve calcification.
N1 Genome Occupancy and Epigenetic Dysregulation
in N1+/– ECs
Determining the transcriptional and epigenetic consequences
of N1 haploinsufficiency occurring directly at N1-bound sitesCell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc. 1083
Figure 7. Model of Mechanisms Regu-
lating Pro-calcific Events in N1 Haploin-
sufficient ECs
(A) Diagram of osteogenic pathways dysregulated
in N1 haploinsufficiency. Red indicates upregula-
tion in N1+/– ECs and blue indicates down-
regulation in N1+/– ECs.
(B) Model of WT ECs. Shear stress activates N1
signaling in ECs, leading to epigenetic changes at
N1-bound enhancers and transcriptional activa-
tion of anti-calcific gene programs that prevent
osteogenesis, inflammation, and oxidative stress
to protect the valve from calcification.
(C) Model of N1+/– ECs, which cannot mediate
the proper response to shear stress, leading to
epigenetic dysregulation at N1-responsive en-
hancers and aberrant upregulation of pro-calcific
regulatory nodes.provides insight into how TF dosage differentially affects targets
leading to human disease. At baseline in WT ECs, gene targets
dysregulated in N1+/– ECs had lower N1 occupancy proximal
to their TSS compared to non-dysregulated targets. Thus, genes
most sensitive to decreased dosage of N1 begin with lower
levels of N1 binding at baseline, potentially placing them closer
to the threshold at which binding becomes insufficient to affect
transcription.
Consistent with previous reports of N1 recruitment of histone
acetyltransferases (Yashiro-Ohtani et al., 2014), N1 binding
sites showed the greatest changes in H3K27ac, compared to
other epigenetic marks, and could not mount the proper epige-
netic response to shear stress in N1+/– ECs. The changes in
H3K27ac correlated with transcriptional dysregulation of puta-
tive direct targets such as ARHGEF17, which we found to be a
major predicted regulatory node, indicating that WT levels of
N1 binding are required to maintain the appropriate epigenetic1084 Cell 160, 1072–1086, March 12, 2015 ª2015 Elsevier Inc.state and transcriptional regulation of
the most sensitive direct targets.
N1 haploinsufficiency had broad
downstream effects on the epigenetic
landscape in ECs. Epigenetic dysregula-
tion extended to DNA methylation, indi-
cating an extensive shift in the regulatory
state of key domains in ECs. CpG shore
regions were the most vulnerable to dys-
regulation, showing the largest enrich-
ment of methylation changes in N1 hap-
loinsufficient ECs. These data support
the notion that CpG shores are the
least stable in the disease state, which
is consistent with previous reports of
shores displaying the most methylation
differences in the context of cancerous
cells and specific tissue types (Irizarry
et al., 2009). This ability to differentiate
between distinct cell states may have
important implications in diagnosis of
disease. For example, DNA methylationmay provide a useful marker for patients who are at risk for valve
calcification.
Identification of Dysregulated Transcriptional Nodes
An incomplete understanding of the molecular mechanisms
involved in the development of CAVD has hampered the design
of effective therapies. By thoroughly interrogating the transcrip-
tional and epigenetic consequences of N1 haploinsufficiency,
we identified transcriptional nodes controlled by SOX7 and
TCF4, where intervention impacted a large portion of the gene
dysregulation in patient-specific ECs. The ability to exert a
concerted influence on gene networks disrupted in cells from
patients with CAVD by targeting discrete regulatory nodes has
potential therapeutic implications. Using this iPSC-based dis-
ease model, we anticipate screening for small molecules that
target central regulatory nodes to inhibit or delay the progres-
sion of calcification in patients at risk for CAVD.
The work presented here demonstrates the value of computa-
tionally integrating genome-wide transcriptome, DNA methyl-
ation, and histone modification data with gene network analyses
to reveal the consequences of human disease-causing muta-
tions. We believe this type of broad and comprehensive
approach will serve as the foundation for rational drug design
for many disorders in the coming years.
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